Top Stories
The Israeli startup is developing AI software to help radiologists interpret breast MRI scans, an area that still lacks an FDA-cleared decision-support tool.
The startup plans to extend its model of pairing prescription medicines with therapeutic software to other disease areas.
Pixel Watch 5 and Fitbit Air will also gain new capabilities for assessing blood pressure trends and breathing during sleep.
The Chinese biotech is developing a small-molecule eye drop for retinal diseases, as well as a second-generation menin inhibitor for leukaemia.
Gilead is using Nucleai AI's Tissue Intelligence platform to better understand why some patients respond to antibody-drug conjugates and others do not.
Conference News
Following a decade of exploration from the 2014 NVIDIA GTC to the PreciousGPT model series, Insilico Medicine presents the industry's first multi-agent Virtual Aging Cell (VAC) platform with biologica...
SAN FRANCISCO--(BUSINESS WIRE)-- Astro Health Inc., a San Francisco-based artificial intelligence digital health company, today announced that its first peer-reviewed research from its clinical study ...
12 Aug 2026Experts' discussions during the ESMO Gastrointestinal Cancers Congress 2026 explored how AI is moving beyond image recognition to support surgery, pathology and image-guided intervention.Th...
University of Colorado Anschutz-led study shows automated oxygen system increases time in target oxygen range and reduces clinician workload compared with standard careAURORA, Colo., Aug. 3, 2026 /PRN...
Following the introduction of Invenia™ ABUS Prime at the Society of Breast Imaging Annual Symposium, the installation at BeSound in Los Angeles marks one of the first in the U.S., expanding access to ...



